Toronto - Delayed Quote CAD
HLS Therapeutics Inc. (HLS.TO)
4.9500
+0.0200
+(0.41%)
At close: June 12 at 3:59:46 PM EDT
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 2 | 1 | 2 | 2 |
| Avg. Estimate | -0.09 | -0.08 | -0.34 | -0.22 |
| Low Estimate | -0.1 | -0.08 | -0.35 | -0.23 |
| High Estimate | -0.07 | -0.08 | -0.32 | -0.2 |
| Year Ago EPS | -0.29 | -- | -0.62 | -0.34 |
Revenue Estimate
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 5 | 5 | 5 | 4 |
| Avg. Estimate | 14.4M | 14.52M | 57.33M | 63.08M |
| Low Estimate | 13.9M | 14M | 56.2M | 59.8M |
| High Estimate | 14.8M | 14.9M | 58.2M | 66.3M |
| Year Ago Sales | 14.52M | 14.09M | 56.62M | 57.33M |
| Sales Growth (year/est) | -0.82% | 3.09% | 1.25% | 10.04% |
Earnings History
| Currency in USD | 6/30/2024 | 9/30/2024 | 12/31/2024 | 3/31/2025 |
|---|---|---|---|---|
| EPS Est. | -0.18 | -0.14 | -0.09 | -0.17 |
| EPS Actual | -0.29 | -0.15 | -0.1 | -0.14 |
| Difference | -0.11 | -0.01 | -0.01 | 0.03 |
| Surprise % | -59.17% | -7.14% | -11.11% | 17.65% |
EPS Trend
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | -0.09 | -0.08 | -0.34 | -0.22 |
| 7 Days Ago | -0.15 | -0.15 | -0.59 | -0.17 |
| 30 Days Ago | -0.15 | -0.15 | -0.59 | -0.17 |
| 60 Days Ago | -0.09 | -0.09 | -0.36 | -0.23 |
| 90 Days Ago | -0.09 | -0.09 | -0.36 | -0.23 |
EPS Revisions
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | 1 | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | -- | -- | -- | 1 |
| Down Last 30 Days | -- | -- | 1 | 1 |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| HLS.TO | 70.33% | -- | 45.97% | 35.82% |
| S&P 500 | 13.13% | 2.45% | 7.55% | 14.06% |
Upgrades & Downgrades
| Maintains | Raymond James: Market Perform to Market Perform | 3/18/2024 |
| Downgrade | Raymond James: Outperform to Market Perform | 8/6/2021 |
Related Tickers
MDP.TO Medexus Pharmaceuticals Inc.
2.9300
-0.68%
DHT-UN.TO DRI Healthcare Trust
13.29
+2.07%
MOB.ST Moberg Pharma AB (publ)
8.24
-2.20%
CTX.TO Crescita Therapeutics Inc.
0.5000
0.00%
GUD.TO Knight Therapeutics Inc.
6.09
+1.50%
CPH.TO Cipher Pharmaceuticals Inc.
13.36
+2.77%
BHC.TO Bausch Health Companies Inc.
7.50
+3.02%
CRON.TO Cronos Group Inc.
2.6900
-0.37%
TXMD TherapeuticsMD, Inc.
1.2000
0.00%
TRUL.CN Trulieve Cannabis Corp.
5.11
+1.19%